BAL - Chart, page-3393

US markets up 2% after Trump delays tariffs.
Today should see at least a 2% uplift in BAL. I am going with 5%.

Reasons to hold:
1. $145m to $170m in H2 sales
2. FY20 projection will likely be $290m to $340m from Aust sales and possibly ~$15m to $30m from ViPlus.
3. If SAMR lands pre H1 FY20, we would have a half year of China sales (add estimated 25% uplift to sales for FY20).
4. FY20 sales could be in the range of $305m (no SAMR) to $463m ($370m x 1.25 with SAMR).

Big upside if you believe. $500m for FY21 is a real possibility should SAMR occur soon.